

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine deamination (GO:0009972) | 6.58676175 |
| 2 | cytidine metabolic process (GO:0046087) | 6.58676175 |
| 3 | cytidine catabolic process (GO:0006216) | 6.58676175 |
| 4 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.25107254 |
| 5 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.92730490 |
| 6 | DNA deamination (GO:0045006) | 5.45180611 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.23670567 |
| 8 | cellular response to interleukin-15 (GO:0071350) | 5.10787046 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.95865202 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.83475645 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.66834621 |
| 12 | regulation of regulatory T cell differentiation (GO:0045589) | 4.49552780 |
| 13 | response to interleukin-15 (GO:0070672) | 4.49212640 |
| 14 | regulation of T cell tolerance induction (GO:0002664) | 4.29581030 |
| 15 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.17539497 |
| 16 | T cell migration (GO:0072678) | 4.15334903 |
| 17 | negative regulation of T cell apoptotic process (GO:0070233) | 4.14328897 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.11410919 |
| 19 | negative regulation of cell killing (GO:0031342) | 4.11410919 |
| 20 | regulation of chronic inflammatory response (GO:0002676) | 4.10208151 |
| 21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.06580423 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 3.90266363 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.89075501 |
| 24 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.88557916 |
| 25 | positive regulation of tolerance induction (GO:0002645) | 3.83302158 |
| 26 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.78513582 |
| 27 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.78513582 |
| 28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.77739521 |
| 29 | negative T cell selection (GO:0043383) | 3.73633133 |
| 30 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.73425860 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.71307977 |
| 32 | regulation of tolerance induction (GO:0002643) | 3.69638384 |
| 33 | positive regulation of B cell differentiation (GO:0045579) | 3.63031168 |
| 34 | mast cell activation (GO:0045576) | 3.59904441 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.59207198 |
| 36 | positive thymic T cell selection (GO:0045059) | 3.58097800 |
| 37 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.56737083 |
| 38 | negative regulation of viral genome replication (GO:0045071) | 3.56718752 |
| 39 | negative thymic T cell selection (GO:0045060) | 3.55921574 |
| 40 | dendritic cell chemotaxis (GO:0002407) | 3.54296717 |
| 41 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.52780842 |
| 42 | granulocyte activation (GO:0036230) | 3.52778675 |
| 43 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.49162209 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.47954706 |
| 45 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.45187487 |
| 46 | actin nucleation (GO:0045010) | 3.44135711 |
| 47 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.42704684 |
| 48 | neutrophil activation (GO:0042119) | 3.42461131 |
| 49 | B cell mediated immunity (GO:0019724) | 3.41646245 |
| 50 | regulation of B cell differentiation (GO:0045577) | 3.41164289 |
| 51 | neutrophil activation involved in immune response (GO:0002283) | 3.37836375 |
| 52 | lymphocyte chemotaxis (GO:0048247) | 3.34521288 |
| 53 | leukocyte aggregation (GO:0070486) | 3.31637098 |
| 54 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.30397655 |
| 55 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.29322470 |
| 56 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.27030604 |
| 57 | regulation of cell killing (GO:0031341) | 3.25237998 |
| 58 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.24782136 |
| 59 | positive regulation of defense response to virus by host (GO:0002230) | 3.24742503 |
| 60 | positive regulation of cell killing (GO:0031343) | 3.23529469 |
| 61 | positive T cell selection (GO:0043368) | 3.22200374 |
| 62 | T cell costimulation (GO:0031295) | 3.20589196 |
| 63 | regulation of activation of Janus kinase activity (GO:0010533) | 3.19135952 |
| 64 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.18133539 |
| 65 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.17732186 |
| 66 | regulation of T cell chemotaxis (GO:0010819) | 3.17222398 |
| 67 | positive regulation of T cell chemotaxis (GO:0010820) | 3.17222398 |
| 68 | lymphocyte costimulation (GO:0031294) | 3.16027261 |
| 69 | leukocyte degranulation (GO:0043299) | 3.12060891 |
| 70 | positive regulation of lymphocyte migration (GO:2000403) | 3.11452003 |
| 71 | T cell selection (GO:0045058) | 3.10798235 |
| 72 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.09599718 |
| 73 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.08185453 |
| 74 | regulation of T cell apoptotic process (GO:0070232) | 3.08165201 |
| 75 | monocyte chemotaxis (GO:0002548) | 3.07552771 |
| 76 | B cell receptor signaling pathway (GO:0050853) | 3.06490327 |
| 77 | T cell receptor signaling pathway (GO:0050852) | 3.04952737 |
| 78 | dendritic cell migration (GO:0036336) | 3.03778133 |
| 79 | activated T cell proliferation (GO:0050798) | 3.03191028 |
| 80 | negative regulation of interleukin-12 production (GO:0032695) | 3.02106036 |
| 81 | eosinophil chemotaxis (GO:0048245) | 3.01962285 |
| 82 | cellular response to type I interferon (GO:0071357) | 2.99574507 |
| 83 | type I interferon signaling pathway (GO:0060337) | 2.99574507 |
| 84 | interferon-gamma production (GO:0032609) | 2.99270973 |
| 85 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.98386397 |
| 86 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.97524463 |
| 87 | natural killer cell differentiation (GO:0001779) | 2.96255092 |
| 88 | response to type I interferon (GO:0034340) | 2.95396295 |
| 89 | thymic T cell selection (GO:0045061) | 2.95070834 |
| 90 | positive regulation of interleukin-17 production (GO:0032740) | 2.94887648 |
| 91 | negative regulation of T cell mediated immunity (GO:0002710) | 2.92669799 |
| 92 | positive regulation of interleukin-2 production (GO:0032743) | 2.87977145 |
| 93 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.87508570 |
| 94 | mast cell activation involved in immune response (GO:0002279) | 2.86884446 |
| 95 | mast cell degranulation (GO:0043303) | 2.86884446 |
| 96 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.84942842 |
| 97 | myeloid cell activation involved in immune response (GO:0002275) | 2.84425113 |
| 98 | positive regulation of macrophage differentiation (GO:0045651) | 2.84335643 |
| 99 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.83728394 |
| 100 | regulation of lymphocyte migration (GO:2000401) | 2.83500616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.29734330 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.81380723 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.35848174 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.08651575 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.51340908 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.47947526 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.96721204 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.19491547 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 3.16297092 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.14438497 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.08696290 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.08428551 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.03003704 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.82653097 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.80388625 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.79571311 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56213372 |
| 18 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.35034731 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.34562126 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.32621061 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23493853 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.19278734 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.13145931 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.11234034 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08405698 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07510287 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.05471885 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.99319895 |
| 29 | GATA3_26560356_Chip-Seq_TH2_Human | 1.97591071 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92768850 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91026496 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.81292352 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.79745613 |
| 34 | MAF_26560356_Chip-Seq_TH2_Human | 1.78803665 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78705794 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.76358077 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71442261 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68008246 |
| 39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.65211096 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64998158 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63719372 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.58281165 |
| 43 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.56508537 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.56141980 |
| 45 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55785004 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.51384173 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42185414 |
| 48 | MYC_22102868_ChIP-Seq_BL_Human | 1.28739558 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26539636 |
| 50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25875661 |
| 51 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.25513651 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19365193 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18311749 |
| 54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11566513 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11080096 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09394264 |
| 57 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.08673273 |
| 58 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.07886903 |
| 59 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07707005 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02169190 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00428079 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99057077 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.98974973 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98449748 |
| 65 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98338747 |
| 66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98204169 |
| 67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.98203351 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97635409 |
| 69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96650342 |
| 70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95445818 |
| 71 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93948968 |
| 72 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92498716 |
| 73 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.91971073 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91251713 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90747395 |
| 76 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90515015 |
| 77 | GATA3_26560356_Chip-Seq_TH1_Human | 0.89219965 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88248651 |
| 79 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80664316 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79471541 |
| 81 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79299131 |
| 82 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78844421 |
| 83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.77934431 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77650203 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77342813 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.77296758 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75130132 |
| 88 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.72646982 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72179893 |
| 90 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.71954776 |
| 91 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.71025750 |
| 92 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.70019948 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69790935 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.69785950 |
| 95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.69246658 |
| 96 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68324400 |
| 97 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.67734297 |
| 98 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.67386939 |
| 99 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.66686322 |
| 100 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.65860607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.84676528 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.96750858 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.47670217 |
| 4 | MP0009785_altered_susceptibility_to | 3.42805400 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.34859240 |
| 6 | MP0003436_decreased_susceptibility_to | 3.30131792 |
| 7 | MP0001800_abnormal_humoral_immune | 3.22036813 |
| 8 | MP0003724_increased_susceptibility_to | 3.14028556 |
| 9 | MP0003763_abnormal_thymus_physiology | 3.09184321 |
| 10 | MP0005387_immune_system_phenotype | 3.04440891 |
| 11 | MP0001790_abnormal_immune_system | 3.04440891 |
| 12 | MP0002723_abnormal_immune_serum | 2.81944330 |
| 13 | MP0000685_abnormal_immune_system | 2.78051499 |
| 14 | MP0005025_abnormal_response_to | 2.77524485 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.74039602 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.63536268 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.62527933 |
| 18 | MP0001819_abnormal_immune_cell | 2.58590979 |
| 19 | MP0006082_CNS_inflammation | 2.54934015 |
| 20 | MP0002419_abnormal_innate_immunity | 2.40931108 |
| 21 | MP0003303_peritoneal_inflammation | 2.34627763 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.15644973 |
| 23 | MP0002398_abnormal_bone_marrow | 2.15269287 |
| 24 | MP0002405_respiratory_system_inflammati | 2.11979847 |
| 25 | MP0000716_abnormal_immune_system | 2.04012941 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.02268043 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.99465455 |
| 28 | MP0004947_skin_inflammation | 1.95603006 |
| 29 | MP0001853_heart_inflammation | 1.84929018 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.84142667 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 1.81791303 |
| 32 | MP0001873_stomach_inflammation | 1.75508954 |
| 33 | MP0002722_abnormal_immune_system | 1.74509996 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.71215973 |
| 35 | MP0009764_decreased_sensitivity_to | 1.70821661 |
| 36 | MP0000703_abnormal_thymus_morphology | 1.63562801 |
| 37 | MP0002429_abnormal_blood_cell | 1.63096948 |
| 38 | MP0003866_abnormal_defecation | 1.62347065 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.59799813 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.53734458 |
| 41 | MP0003448_altered_tumor_morphology | 1.44991806 |
| 42 | MP0008469_abnormal_protein_level | 1.41850377 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.31288757 |
| 44 | MP0002006_tumorigenesis | 1.30774969 |
| 45 | MP0000858_altered_metastatic_potential | 1.30027206 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.27033461 |
| 47 | MP0004381_abnormal_hair_follicle | 1.24887761 |
| 48 | MP0008004_abnormal_stomach_pH | 1.24196850 |
| 49 | MP0000343_altered_response_to | 1.20391894 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.20311537 |
| 51 | MP0002933_joint_inflammation | 1.19364563 |
| 52 | MP0005310_abnormal_salivary_gland | 1.18334737 |
| 53 | MP0003075_altered_response_to | 1.17785166 |
| 54 | MP0009763_increased_sensitivity_to | 1.11252757 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.10301752 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.10056787 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.07669826 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.07668134 |
| 59 | MP0003045_fibrosis | 1.06910478 |
| 60 | MP0004510_myositis | 1.02857771 |
| 61 | MP0000569_abnormal_digit_pigmentation | 1.00970968 |
| 62 | MP0005166_decreased_susceptibility_to | 0.94847360 |
| 63 | MP0009278_abnormal_bone_marrow | 0.92435404 |
| 64 | MP0009765_abnormal_xenobiotic_induced | 0.91136552 |
| 65 | MP0000604_amyloidosis | 0.89832442 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 0.88689759 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 0.88022426 |
| 68 | MP0009840_abnormal_foam_cell | 0.85869357 |
| 69 | MP0002132_abnormal_respiratory_system | 0.81397807 |
| 70 | MP0002254_reproductive_system_inflammat | 0.79925003 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 0.77510270 |
| 72 | MP0001851_eye_inflammation | 0.77038847 |
| 73 | MP0001663_abnormal_digestive_system | 0.76182204 |
| 74 | MP0000249_abnormal_blood_vessel | 0.72031991 |
| 75 | MP0002009_preneoplasia | 0.68238631 |
| 76 | MP0002019_abnormal_tumor_incidence | 0.66783848 |
| 77 | MP0002693_abnormal_pancreas_physiology | 0.65847243 |
| 78 | MP0005390_skeleton_phenotype | 0.62924005 |
| 79 | MP0008873_increased_physiological_sensi | 0.59258167 |
| 80 | MP0005397_hematopoietic_system_phenotyp | 0.59194168 |
| 81 | MP0001545_abnormal_hematopoietic_system | 0.59194168 |
| 82 | MP0003828_pulmonary_edema | 0.59025416 |
| 83 | MP0000490_abnormal_crypts_of | 0.57407600 |
| 84 | MP0002139_abnormal_hepatobiliary_system | 0.55625795 |
| 85 | MP0001501_abnormal_sleep_pattern | 0.55084956 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 0.54468305 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.54048247 |
| 88 | MP0000920_abnormal_myelination | 0.52318770 |
| 89 | MP0003795_abnormal_bone_structure | 0.52246645 |
| 90 | MP0005164_abnormal_response_to | 0.49640329 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.49380269 |
| 92 | MP0008874_decreased_physiological_sensi | 0.48269608 |
| 93 | MP0010307_abnormal_tumor_latency | 0.47953187 |
| 94 | MP0005174_abnormal_tail_pigmentation | 0.47370904 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.46431966 |
| 96 | MP0004036_abnormal_muscle_relaxation | 0.46398556 |
| 97 | MP0005379_endocrine/exocrine_gland_phen | 0.45117516 |
| 98 | MP0006035_abnormal_mitochondrial_morpho | 0.44829734 |
| 99 | MP0001727_abnormal_embryo_implantation | 0.44210710 |
| 100 | MP0002102_abnormal_ear_morphology | 0.42749860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.51711072 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.04931690 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.13373630 |
| 4 | Stomatitis (HP:0010280) | 5.11436142 |
| 5 | Increased IgM level (HP:0003496) | 5.00568857 |
| 6 | IgG deficiency (HP:0004315) | 4.71614789 |
| 7 | Severe combined immunodeficiency (HP:0004430) | 4.44662784 |
| 8 | Abnormality of T cells (HP:0002843) | 4.34146854 |
| 9 | Autoimmune hemolytic anemia (HP:0001890) | 4.27371576 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.19780195 |
| 11 | Myositis (HP:0100614) | 4.05033834 |
| 12 | Chronic diarrhea (HP:0002028) | 3.94572779 |
| 13 | Combined immunodeficiency (HP:0005387) | 3.84734089 |
| 14 | Abnormality of eosinophils (HP:0001879) | 3.81721802 |
| 15 | Aplastic anemia (HP:0001915) | 3.78986490 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 3.78920772 |
| 17 | Recurrent viral infections (HP:0004429) | 3.78842787 |
| 18 | Optic neuritis (HP:0100653) | 3.67944439 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.67944439 |
| 20 | Abnormality of B cell number (HP:0010975) | 3.66024206 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.64839213 |
| 22 | Recurrent abscess formation (HP:0002722) | 3.61355710 |
| 23 | Encephalitis (HP:0002383) | 3.58425947 |
| 24 | Meningitis (HP:0001287) | 3.57592051 |
| 25 | Orchitis (HP:0100796) | 3.47261095 |
| 26 | Leukocytosis (HP:0001974) | 3.44072599 |
| 27 | Vasculitis (HP:0002633) | 3.42602001 |
| 28 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.42493371 |
| 29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.42493371 |
| 30 | Abnormality of glycolipid metabolism (HP:0010969) | 3.42493371 |
| 31 | B lymphocytopenia (HP:0010976) | 3.41549849 |
| 32 | Thyroiditis (HP:0100646) | 3.40154555 |
| 33 | Eosinophilia (HP:0001880) | 3.36823165 |
| 34 | Obstructive lung disease (HP:0006536) | 3.36048106 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 3.36048106 |
| 36 | Pulmonary infiltrates (HP:0002113) | 3.34254678 |
| 37 | Abnormality of the prostate (HP:0008775) | 3.32089017 |
| 38 | Autoimmune thrombocytopenia (HP:0001973) | 3.31555100 |
| 39 | Recurrent bronchitis (HP:0002837) | 3.31291064 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.29344803 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 3.29344803 |
| 42 | Petechiae (HP:0000967) | 3.23173307 |
| 43 | Eczematoid dermatitis (HP:0000976) | 3.20846761 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 3.15837987 |
| 45 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.14601467 |
| 46 | Granulocytopenia (HP:0001913) | 3.08282623 |
| 47 | Hypergammaglobulinemia (HP:0010702) | 3.01083997 |
| 48 | Hypoplasia of the thymus (HP:0000778) | 2.99691185 |
| 49 | Agammaglobulinemia (HP:0004432) | 2.95339927 |
| 50 | Recurrent skin infections (HP:0001581) | 2.95057480 |
| 51 | Joint swelling (HP:0001386) | 2.89808940 |
| 52 | Purpura (HP:0000979) | 2.88480043 |
| 53 | Pustule (HP:0200039) | 2.86893264 |
| 54 | Hypoproteinemia (HP:0003075) | 2.84869363 |
| 55 | Lymphopenia (HP:0001888) | 2.77978685 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.73467268 |
| 57 | Abnormality of T cell physiology (HP:0011840) | 2.69314400 |
| 58 | Gangrene (HP:0100758) | 2.65830271 |
| 59 | IgM deficiency (HP:0002850) | 2.65502319 |
| 60 | Epistaxis (HP:0000421) | 2.65500627 |
| 61 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.63001356 |
| 62 | Hemoptysis (HP:0002105) | 2.61469854 |
| 63 | Keratoconjunctivitis (HP:0001096) | 2.54279693 |
| 64 | Pulmonary embolism (HP:0002204) | 2.51256527 |
| 65 | Lymphoma (HP:0002665) | 2.50528014 |
| 66 | Prolonged bleeding time (HP:0003010) | 2.49739093 |
| 67 | Panhypogammaglobulinemia (HP:0003139) | 2.49588201 |
| 68 | Spontaneous hematomas (HP:0007420) | 2.48264224 |
| 69 | IgA deficiency (HP:0002720) | 2.43570916 |
| 70 | Acute hepatic failure (HP:0006554) | 2.41311071 |
| 71 | Abnormality of the pleura (HP:0002103) | 2.32662586 |
| 72 | Polyneuropathy (HP:0001271) | 2.23140975 |
| 73 | Increased cerebral lipofuscin (HP:0011813) | 2.18205484 |
| 74 | Pulmonary fibrosis (HP:0002206) | 2.17487095 |
| 75 | Chest pain (HP:0100749) | 2.17254784 |
| 76 | Increased IgE level (HP:0003212) | 2.13720832 |
| 77 | Hepatosplenomegaly (HP:0001433) | 2.12126211 |
| 78 | Arterial thrombosis (HP:0004420) | 2.10746624 |
| 79 | Dysostosis multiplex (HP:0000943) | 2.09802856 |
| 80 | Urticaria (HP:0001025) | 2.08847307 |
| 81 | Vacuolated lymphocytes (HP:0001922) | 2.07674074 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 2.07367767 |
| 83 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.05587169 |
| 84 | Episodic fever (HP:0001954) | 2.04427270 |
| 85 | Glomerulopathy (HP:0100820) | 2.02167406 |
| 86 | Alveolar cell carcinoma (HP:0006519) | 2.01885925 |
| 87 | Gastrointestinal stroma tumor (HP:0100723) | 2.01011197 |
| 88 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00632940 |
| 89 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97425993 |
| 90 | Anorexia (HP:0002039) | 1.95107166 |
| 91 | Gingival bleeding (HP:0000225) | 1.94480716 |
| 92 | Skin rash (HP:0000988) | 1.94385200 |
| 93 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.87834107 |
| 94 | Progressive neurologic deterioration (HP:0002344) | 1.85795059 |
| 95 | Bronchitis (HP:0012387) | 1.85791346 |
| 96 | Increased serum ferritin (HP:0003281) | 1.84661597 |
| 97 | Papilledema (HP:0001085) | 1.84653873 |
| 98 | Arthralgia (HP:0002829) | 1.82426433 |
| 99 | Abnormality of male internal genitalia (HP:0000022) | 1.81810541 |
| 100 | Basal ganglia calcification (HP:0002135) | 1.80868029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.24154218 |
| 2 | MAP4K1 | 3.86291134 |
| 3 | RIPK4 | 3.22701911 |
| 4 | KDR | 2.82636059 |
| 5 | TAOK3 | 2.78452730 |
| 6 | FES | 2.73672517 |
| 7 | MST4 | 2.61933558 |
| 8 | TESK2 | 2.42555504 |
| 9 | GRK7 | 2.30865682 |
| 10 | MAP3K14 | 2.12717218 |
| 11 | IRAK4 | 2.04723989 |
| 12 | ZAP70 | 2.04715560 |
| 13 | CSK | 1.97542028 |
| 14 | SYK | 1.91232438 |
| 15 | IKBKB | 1.90059883 |
| 16 | TBK1 | 1.84278928 |
| 17 | MATK | 1.82428803 |
| 18 | BTK | 1.79331470 |
| 19 | TLK1 | 1.75160350 |
| 20 | BLK | 1.75090557 |
| 21 | IKBKE | 1.72601959 |
| 22 | ITK | 1.69481661 |
| 23 | BMPR2 | 1.58403397 |
| 24 | ADRBK2 | 1.57796169 |
| 25 | TNK2 | 1.52350923 |
| 26 | LCK | 1.45235053 |
| 27 | TEC | 1.42569138 |
| 28 | KIT | 1.42198442 |
| 29 | LYN | 1.39380912 |
| 30 | CSF1R | 1.37059770 |
| 31 | PRKCQ | 1.34597325 |
| 32 | JAK1 | 1.32139411 |
| 33 | PIK3CG | 1.26629492 |
| 34 | GRK6 | 1.22286411 |
| 35 | TESK1 | 1.19119718 |
| 36 | SIK3 | 1.18391521 |
| 37 | TYK2 | 1.18261046 |
| 38 | IRAK3 | 1.15170060 |
| 39 | MAPKAPK3 | 1.14564068 |
| 40 | JAK3 | 1.13520610 |
| 41 | HCK | 1.12899314 |
| 42 | ZAK | 1.09271755 |
| 43 | BCKDK | 0.99906396 |
| 44 | DAPK1 | 0.99775462 |
| 45 | MAP3K12 | 0.98746516 |
| 46 | ERN1 | 0.96774031 |
| 47 | MARK3 | 0.95876046 |
| 48 | JAK2 | 0.91350854 |
| 49 | FGR | 0.91300427 |
| 50 | STK10 | 0.89381671 |
| 51 | TAOK2 | 0.88640706 |
| 52 | MAP2K6 | 0.82903027 |
| 53 | SCYL2 | 0.79956798 |
| 54 | MAP2K3 | 0.79725565 |
| 55 | DAPK2 | 0.77787931 |
| 56 | PRPF4B | 0.74586982 |
| 57 | TGFBR2 | 0.73208835 |
| 58 | MAP3K3 | 0.73145728 |
| 59 | EIF2AK3 | 0.71568461 |
| 60 | PIM1 | 0.63981152 |
| 61 | MAPK7 | 0.63679570 |
| 62 | MYLK | 0.61904779 |
| 63 | PDK1 | 0.60933033 |
| 64 | TRIM28 | 0.59406721 |
| 65 | MAP3K5 | 0.58101339 |
| 66 | RPS6KA4 | 0.56693136 |
| 67 | FYN | 0.56663866 |
| 68 | MAPK12 | 0.55497931 |
| 69 | MAP3K13 | 0.53313984 |
| 70 | CHUK | 0.52186179 |
| 71 | CLK1 | 0.49806677 |
| 72 | MAP3K11 | 0.48307198 |
| 73 | GRK5 | 0.47499762 |
| 74 | EPHA3 | 0.47236578 |
| 75 | IRAK1 | 0.44655086 |
| 76 | TAF1 | 0.43501611 |
| 77 | MAPKAPK2 | 0.42253941 |
| 78 | PIM2 | 0.41756946 |
| 79 | NLK | 0.40920561 |
| 80 | IGF1R | 0.37899515 |
| 81 | MOS | 0.36913780 |
| 82 | PDGFRB | 0.36629073 |
| 83 | VRK1 | 0.33699015 |
| 84 | DAPK3 | 0.32911028 |
| 85 | TYRO3 | 0.32368696 |
| 86 | RPS6KA5 | 0.31604422 |
| 87 | ABL1 | 0.30672743 |
| 88 | PTK2B | 0.30560416 |
| 89 | INSR | 0.29101375 |
| 90 | MUSK | 0.28503479 |
| 91 | TRPM7 | 0.27464647 |
| 92 | MAPK11 | 0.26870987 |
| 93 | BMX | 0.25183483 |
| 94 | PRKCD | 0.25037537 |
| 95 | TAOK1 | 0.23514941 |
| 96 | MAP3K1 | 0.21707607 |
| 97 | EGFR | 0.19905418 |
| 98 | ACVR1B | 0.19820647 |
| 99 | IRAK2 | 0.18968451 |
| 100 | CDK4 | 0.17176880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.10393999 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.40389977 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.28899830 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.23879715 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.86406609 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.82245891 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.76555843 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.73478413 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.67503048 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.46799718 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.44308800 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.43474245 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.41068907 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.38225181 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.34028967 |
| 16 | Measles_Homo sapiens_hsa05162 | 2.26960936 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.13500091 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 2.11256414 |
| 19 | Asthma_Homo sapiens_hsa05310 | 2.06798989 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.03816809 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.03040105 |
| 22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.86052864 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.82094675 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.66150867 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.62722681 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.54563959 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53490719 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44235293 |
| 29 | Salmonella infection_Homo sapiens_hsa05132 | 1.40240963 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.39573377 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.38690677 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.37129948 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.32406421 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.31068425 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.23912080 |
| 36 | Proteasome_Homo sapiens_hsa03050 | 1.23127092 |
| 37 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.19721567 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19337588 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.16859739 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05914078 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01300659 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 0.94791477 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94070126 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 0.93434959 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91036516 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 0.88032611 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84828362 |
| 48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81675216 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 0.75188518 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.74838101 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.72882812 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72315195 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69520975 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66368127 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59336342 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58378393 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.57465002 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54713543 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54282661 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51125846 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50163980 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45976522 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45600388 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.45022882 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44303508 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44065002 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40919976 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38711197 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35974952 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33693420 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33278573 |
| 72 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.32836272 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.31836157 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30235740 |
| 75 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27005998 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24027655 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20946322 |
| 78 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.20731013 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20621286 |
| 80 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19649094 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.16463456 |
| 82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.15027192 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.14343430 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14191295 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.11842026 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.11268096 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.09969441 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.04780242 |
| 89 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.02733818 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.02715972 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.02542553 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.02095283 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.01134543 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.00828187 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.00591126 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.00479216 |
| 97 | Phototransduction_Homo sapiens_hsa04744 | -0.0461763 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | -0.0441785 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0172879 |
| 100 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0147207 |

